🔥 Hot Today in Peptide Research

🔥🔥🔥

Public-health experts weigh in on the social-media peptide wave

Photo: The Lazy Artist Gallery / StockSnap (CC0) / own upload

Harvard T.H. Chan School of Public Health published a Q&A on 1 October with Professor S. Bryn Austin about the peptides now being promoted by influencers, including BPC-157, TB-500, MOTS-c, CJC-1295 and ipamorelin. She said many have had little or no rigorous clinical testing and are not FDA-approved, and that with gray-market and so-called "research chemical" sellers nobody can be sure what a vial actually contains. For laboratory buyers, the takeaway is that batch-level identity and purity data matter most.

For research-community awareness only. Not legal advice. For research use only. Not for human or veterinary use. Not a drug, food, or cosmetic.

BioLabs Research has no affiliation with, and no endorsement from, any person named. Source: Harvard T.H. Chan School of Public Health

🔥🔥

Phase 3 data published for an investigational incretin-class compound

Photo: HD Wallpapers / StockSnap (CC0) / own upload

The BMJ reported on 1 October on newly published phase 3 trial data for an investigational incretin-class compound that has not been approved by any regulatory agency. The BMJ also pointed to growing concern about unapproved products of this class sold online, and the UK MHRA warned this summer against "the online hype" around it.

For research-community awareness only. Not legal advice.

🔥🔥

FDA posts nationwide recall of compounded glutathione over endotoxin

Photo: Build Tier List / StockSnap (CC0) / own upload

FDA posted a company announcement on 1 October in which a Texas 503A compounding pharmacy is voluntarily recalling lots of compounded glutathione, a naturally occurring tripeptide, because of potentially elevated endotoxin levels. The lots were distributed nationwide between 26 June and 21 September 2026. The firm reported two emergency-care cases after the product was given by a route it was not formulated for; in research settings, endotoxin is a key quality attribute for peptide materials, because it can trigger inflammatory signalling in cell assays that may be mistaken for a compound effect.

For research-community awareness only. Not legal advice.